Bhavesh Ashar
CIK 1849740 · Chief Operating Officer · last filed 2026-05-07
Bhavesh Ashar is a Chief Operating Officer who has filed 14 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for TYRA, was dated May 7, 2026. Across all open-market trades the lifetime net is −$443.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $405.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$405.2K
2
14
-$443.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TYRA | Chief Operating Officer | 15,013 | $26.99 | $405.2K | $0 | 2 | 2026-05-07 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Commercial Officer | 0 | $46.99 | $0 | -$443.6K | 12 | 2025-07-02 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | TYRA | Grant (A) | +15,013 | $0 | EDGAR |
| 2025-12-01 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Disp (D) | −62,053 | $0 | EDGAR |
| 2025-02-24 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −1,016 | -$62.2K | EDGAR |
| 2025-01-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +17,323 | $0 | EDGAR |
| 2025-01-07 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −10,584 | -$405.7K | EDGAR |
| 2024-04-03 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −1,824 | -$86.9K | EDGAR |
| 2024-02-05 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −8,056 | -$381.4K | EDGAR |
| 2024-01-08 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +22,489 | -$155.3K | EDGAR |
| 2023-04-05 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −1,375 | -$34.7K | EDGAR |